Acquiring Company
Genesystem
Acquired Company
Odecaribe
Description
Genesystem decided on Nov. 16, 2026 to acquire the Odecaribe business from Kang Ji-wan, who will receive the rights and assets from Maxism, Rotra, and Kertier. The deal is valued at about 3.3 billion won and will be paid in treasury shares and perpetual convertible bonds. The structure has drawn criticism over its transparency.
Quick answer
Genesystem is acquiring Odecaribe, announced November 18, 2026. Genesystem is based in Daejeon, Daejeon, South Korea.
- How much did Genesystem pay for Odecaribe?
- The deal value was not disclosed.
- What does Genesystem do?
- Genesystem is a molecular diagnostics company listed on KOSDAQ.
- Where are Genesystem and Odecaribe based?
- Genesystem is based in Daejeon, Daejeon, South Korea. Odecaribe is based in South Korea.
Source: Fundz verified event record.
Other recent acquisitions in Fashion and Beauty
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- The Center Brands acquires Boscia from FANCL (October 26, 2026)
- BorboletaPro acquires Dulce Lash Artistry (October 16, 2026)
- Galderma to acquire ZO Skin Health for skincare boost (October 14, 2026)
- BeautyPro acquires Supercover for cosmetics growth (October 13, 2026)
- L'Oreal acquires Dr.G for U.S. market expansion (October 5, 2026)
- Everis Medical combines with Hemostasis (November 17, 2026)
Who to call at Genesystem, and when
When Genesystem changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Genesystem raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Genesystem, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Genesystem. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Genesystem makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Odecaribe?
Odecaribe was acquired by Genesystem, based in Daejeon. The deal was reported on November 18, 2026. Genesystem is a molecular diagnostics company listed on KOSDAQ. The company's revenue has declined sharply since the end of the COVID-19 pandemic. It is pursuing acquisitions to lift revenue and maintain its listing. Genesystem is privately held and operates in Biotechnology.
When did Genesystem acquire Odecaribe?
Genesystem's acquisition of Odecaribe was reported on November 18, 2026. Genesystem decided on Nov. 16, 2026 to acquire the Odecaribe business from Kang Ji-wan, who will receive the rights and assets from Maxism, Rotra, and Kertier. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Odecaribe do?
Odecaribe is a shampoo and hair care brand. The business rights and assets are held by three corporations: Maxism, Rotra, and Kertier. The brand was run with an individual holding its trademark. It is privately held, operating in Health Care, and is based in South Korea.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.